16,090 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Acquired by State Board of Administration of Florida Retirement System

State Board of Administration of Florida Retirement System purchased a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 16,090 shares of the company’s stock, valued at approximately $103,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Captrust Financial Advisors raised its stake in shares of Hims & Hers Health by 1,827.4% during the first quarter. Captrust Financial Advisors now owns 6,765 shares of the company’s stock worth $36,000 after buying an additional 6,414 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of Hims & Hers Health during the third quarter worth approximately $51,000. Tower Research Capital LLC TRC raised its stake in shares of Hims & Hers Health by 70.2% during the third quarter. Tower Research Capital LLC TRC now owns 9,538 shares of the company’s stock worth $54,000 after buying an additional 3,933 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Hims & Hers Health by 61.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,539 shares of the company’s stock worth $81,000 after buying an additional 5,524 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in Hims & Hers Health in the third quarter valued at approximately $95,000. 45.60% of the stock is owned by institutional investors.

Hims & Hers Health Trading Down 3.2 %

Hims & Hers Health stock opened at $9.20 on Wednesday. The company has a market cap of $1.93 billion, a P/E ratio of -31.72 and a beta of 0.47. Hims & Hers Health, Inc. has a 1-year low of $3.32 and a 1-year high of $12.34. The company has a fifty day simple moving average of $10.43 and a 200 day simple moving average of $8.56.

Hims & Hers Health (NYSE:HIMS – Get Rating) last released its earnings results on Monday, May 8th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. The business had revenue of $190.80 million during the quarter, compared to the consensus estimate of $179.07 million. Hims & Hers Health had a negative net margin of 9.65% and a negative return on equity of 18.97%. The firm’s revenue for the quarter was up 88.4% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.08) earnings per share. On average, equities research analysts forecast that Hims & Hers Health, Inc. will post -0.21 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on HIMS. Truist Financial upped their target price on shares of Hims & Hers Health from $7.00 to $12.00 and gave the company a “hold” rating in a research note on Tuesday, February 28th. Piper Sandler upped their target price on shares of Hims & Hers Health from $11.00 to $12.00 in a research note on Tuesday, May 9th. Bank of America upped their target price on shares of Hims & Hers Health from $13.50 to $15.00 in a research note on Tuesday, May 9th. Guggenheim upped their target price on shares of Hims & Hers Health from $15.00 to $18.00 in a research note on Thursday, April 27th. Finally, Credit Suisse Group increased their price objective on shares of Hims & Hers Health from $8.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 1st. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $12.00.

Insider Buying and Selling at Hims & Hers Health

In other Hims & Hers Health news, Director Alex Bard sold 500,000 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $11.55, for a total value of $5,775,000.00. Following the completion of the sale, the director now owns 296,878 shares in the company, valued at $3,428,940.90. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Hims & Hers Health news, Director Alex Bard sold 500,000 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $11.55, for a total value of $5,775,000.00. Following the completion of the sale, the director now owns 296,878 shares in the company, valued at $3,428,940.90. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Melissa Baird sold 19,032 shares of the firm’s stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $12.04, for a total transaction of $229,145.28. Following the sale, the chief operating officer now owns 416,513 shares of the company’s stock, valued at approximately $5,014,816.52. The disclosure for this sale can be found here. Insiders sold a total of 722,285 shares of company stock worth $8,033,062 over the last quarter. 35.22% of the stock is currently owned by insiders.

Hims & Hers Health Profile

(Get Rating)

Hims & Hers Health, Inc operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.